Therefore, it may be difficult to draw any definitive conclusions regarding the main tumor’s mutation-specific characteristics in advanced-stage EGFR-positive lung cancer, although our findings indicate that EGFR-positive tumors exhibit unique characteristics, compared to the other molecular subtypes. The gene discussed is EGFR; the disease is neoplasm.